We are live on
!
Find out more
Loomis, Sayles & Company Portfolio holdings
AUM
$74.3B
1-Year Est. Return
24.01%
This Fund
S&P 500
This Quarter
Est. Return
-8.36%
1 Year Est. Return
+24.01%
3 Year Est. Return
+109.67%
5 Year Est. Return
+145.58%
10 Year Est. Return
+623.08%
AUM
$74.3B
AUM Growth
-$8.62B
(-10%)
Cap. Flow
-$532M
Cap. Flow
% of AUM
-0.72%
Top 10 Holdings %
Top 10 Hldgs %
52.32%
Holding
784
New
89
Increased
180
Reduced
401
Closed
66
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Booking.com
BKNG
|
+$556M |
| 2 |
NVIDIA
NVDA
|
+$117M |
| 3 |
Oracle
ORCL
|
+$104M |
| 4 |
Amazon
AMZN
|
+$79.8M |
| 5 |
Expedia Group
EXPE
|
+$77.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Illumina
ILMN
|
+$161M |
| 2 |
Parker-Hannifin
PH
|
+$138M |
| 3 |
Cummins
CMI
|
+$94.8M |
| 4 |
Mettler-Toledo International
MTD
|
+$82.8M |
| 5 |
Home Depot
HD
|
+$77.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.44% |
| 2 | Communication Services | 20.45% |
| 3 | Consumer Discretionary | 17.53% |
| 4 | Healthcare | 11.66% |
| 5 | Industrials | 9.52% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
126
Cactus
WHD
$4.3B
| $40M | 0.05% |
843,693
-70,398
| -8% | -$3.69M |
|
127
Viavi Solutions
VIAV
$8.65B
| $39.2M | 0.05% |
1,176,860
-92,769
| -7% | -$2.45M |
|
128
Jazz Pharmaceuticals
JAZZ
$16.2B
| $38.9M | 0.05% |
205,905
+89,458
| +77% | +$15.6M |
|
129
Grand Canyon Education
LOPE
$3.98B
| $38.9M | 0.05% |
228,530
-19,068
| -8% | -$3.2M |
|
130
BWX Technologies
BWXT
$15.2B
| $38.7M | 0.05% |
189,244
-4,450
| -2% | -$904K |
|
131
SouthState Bank Corp
SSB
$10.2B
| $38.5M | 0.05% |
416,233
-3,432
| -0.8% | -$337K |
|
132
RadNet
RDNT
$4.93B
| $38.4M | 0.05% |
686,215
-57,257
| -8% | -$3.91M |
|
133
Casey's General Stores
CASY
$32.1B
| $37.7M | 0.05% |
51,829
-1,312
| -2% | -$855K |
|
134
Alignment Healthcare
ALHC
$3.85B
| $37.1M | 0.05% |
2,106,068
-129,990
| -6% | -$2.61M |
|
135
Prosperity Bancshares
PB
$8.97B
| $36.4M | 0.05% |
541,133
-4,110
| -0.8% | -$288K |
|
136
Artivion
AORT
$1.34B
| $35.9M | 0.05% |
980,439
+140,377
| +17% | +$5.54M |
|
137
TechnipFMC
FTI
$27.5B
| $35.8M | 0.05% |
518,372
-49,364
| -9% | -$2.97M |
|
138
Home BancShares
HOMB
$6.25B
| $35.6M | 0.05% |
1,321,846
-20,589
| -2% | -$580K |
|
|
SOLS
139
Solstice Advanced Materials
SOLS
$9.12B
| $35.6M | 0.05% |
467,035
-18,747
| -4% | -$1.28M |
|
140
Ciena
CIEN
$52.7B
| $35.5M | 0.05% |
91,313
-54,669
| -37% | -$16.7M |
|
141
NXP Semiconductors
NXPI
$61.8B
| $35.2M | 0.05% |
178,586
+19,498
| +12% | +$4.32M |
|
|
GRDN
142
Guardian Pharmacy Services
GRDN
$2.61B
| $35.1M | 0.05% |
931,689
+296,068
| +47% | +$9.67M |
|
143
Reinsurance Group of America
RGA
$15.6B
| $35M | 0.05% |
171,484
-2,084
| -1% | -$431K |
|
144
UGI
UGI
$7.76B
| $34.5M | 0.05% |
946,556
-24,098
| -2% | -$907K |
|
|
AD
145
Array Digital Infrastructure
AD
$3.02B
| $34.2M | 0.05% |
740,481
-21,205
| -3% | -$1.06M |
|
146
PTC Therapeutics
PTCT
$6.26B
| $33.6M | 0.05% |
+493,603
| New | +$35M |
|
147
MSCI
MSCI
$41.9B
| $33.6M | 0.05% |
62,356
-1,164
| -2% | -$656K |
|
148
Vontier
VNT
$4.49B
| $33.4M | 0.05% |
942,653
-27,936
| -3% | -$1.08M |
|
149
Option Care Health
OPCH
$3.36B
| $33.3M | 0.04% |
1,237,747
-9,676
| -0.8% | -$314K |
|
150
Huron Consulting
HURN
$2.61B
| $33.2M | 0.04% |
260,212
-21,713
| -8% | -$3.26M |
|
Similar funds
CBU
BC
Loomis, Sayles & Company's Q1 2026 Portfolio in Review
As of Q1 2026, Loomis, Sayles & Company held 784 positions worth $74.3B, down 10% from $83B the previous quarter. Its ten largest holdings account for 52% of the portfolio.
Loomis, Sayles & Company's Q1 2026 filing shows 89 new, 180 increased, 401 reduced and 66 closed positions. Its largest new stake was PTC Therapeutics: 493,603 shares worth $33.6M. The largest sale was Illumina, an estimated $161M.
By sector, the portfolio is most concentrated in Technology at 26% of assets, down from 28% a quarter earlier, followed by Communication Services and Consumer Discretionary.
- Loomis, Sayles & Company's largest Q1 2026 buy was PTC Therapeutics: 493,603 shares worth $33.6M.
- Loomis, Sayles & Company added most to Booking.com in Q1 2026, an estimated $556M increase.
- Loomis, Sayles & Company's biggest Q1 2026 reduction was Illumina, cutting an estimated $161M.
- Loomis, Sayles & Company fully exited Wave Life Sciences in Q1 2026, selling an estimated $34.7M.
- Loomis, Sayles & Company's ten largest holdings make up 52% of its $74.3B portfolio in Q1 2026.
- Loomis, Sayles & Company opened 89 new positions and closed 66 in Q1 2026.
- Loomis, Sayles & Company's portfolio value fell 10% quarter-over-quarter to $74.3B.
Based on Loomis, Sayles & Company's 13F filing for Q1 2026, filed 14 May 2026.